Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Small Cell Lung Carcinoma × Vincristine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 26 Lymphoma, Follicular 17 Lymphoma, Non-Hodgkin 16 Lymphoma 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma, B-Cell 10 Neoplasms 8 Lymphoma, Mantle-Cell 7 Lymphoma, T-Cell, Peripheral 6 Recurrence 5 Leukemia 5 Hematologic Diseases 4 Sarcoma, Kaposi 3 Neuroblastoma 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 HIV Infections 3 Acquired Immunodeficiency Syndrome 3 Wilms Tumor 2 Lymphoma, T-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Leukemia, Myeloid, Acute 2 Burkitt Lymphoma 2 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Oligodendroglioma 1 Neurocytoma 1 Neoplasms by Histologic Type 1

Interventions

Carboplatin 56 Etoposide 51 Topotecan 34 Cisplatin 30 pembrolizumab 22 atezolizumab 22 durvalumab 19 Paclitaxel 12 PM 01183 11 Nivolumab 11 rovalpituzumab tesirine 10 Pemetrexed 8 AMG 757 8 trilaciclib 7 amrubicin 7 Ipilimumab 7 Injections 6 Irinotecan 5 Drug Therapy 5 Bevacizumab 5 tremelimumab 4 olaparib 4 budigalimab 4 MLN 8237 4 Docetaxel 4 Dexamethasone 4 Cyclophosphamide 4 venetoclax 3 lenvatinib 3 fludarabine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02566993 2021-10-28

ATLANTIS

PharmaMar

Phase 3 Completed

613 enrolled 46 charts

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡